ISRCTN72730583已完成未知
The effect of insulin detemir on energy balance, postprandial nutrient handling, body fat distribution and adipose tissue metabolism and gene expression in patients with type 2 diabetes
niversity of Surrey (UK)0 个研究点目标入组 22 人开始时间: 2010年7月30日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Type 2 diabetes
- •2. Treated with metformin
- •3. Already on treatment with a long-acting or intermediate insulin
- •4. Aged greater than or equal to 18 years of age, either sex
- •5. HbA1c greater than 7.0%
- •6. Body mass index (BMI) 27 - 40 kg/m^2
- •7. Able and willing to perform self-blood glucose monitoring
- •8. Able and willing to maintain consistent eating habits throughout the entire trial period
- •9. Able and willing to maintain consistent physical activity level during the entire trial period
排除标准
- •1. Patients on sulphonylureas or thiazolidinediones
- •2. Proliferative retinopathy that has required acute treatment within the last six months
- •3. Impaired hepatic or renal functions
- •4. Cardiac problems
- •5. Uncontrolled hypertension (treated or untreated)
- •6. Mental incapacity, unwillingness or a language barrier precluding adequate understanding or co-operation
研究者
相似试验
进行中（未招募）
1 期
The effect of insulin detemir on energy balance, postprandial nutrient handling, body fat distribution,and adipose tissue metabolism and gene expression in patients with type 2 diabetes. - Metabolic Effects of DetemirType 2 Diabetes MellitusEUCTR2007-003085-17-GBniversity of Surrey30
进行中（未招募）
1 期
The effect of insulin detemir in combination with liraglutide and metformin compared to liraglutide and metformin in subjects with type 2 diabetes. A 26-week, randomised, open-label, parallel-group, multicentre, multinational trial with a 26-week extensioType 2 diabetesMedDRA version: 9.1 Level: LLT Classification code 10045242 Term: Type II diabetes mellitusEUCTR2007-005317-19-GBovo Nordisk A/S940
进行中（未招募）
不适用
The effect of insulin detemir in combination with liraglutide and metformin compared to liraglutide and metformin in subjects with type 2 diabetes. A 26-week, randomised, open-label, parallel-group, multicentre, multinational trial with a 26-week extension - NDEUCTR2007-005317-19-ITOVO NORDISK940
进行中（未招募）
1 期
The effect of insulin detemir in combination with liraglutide and metformin compared to liraglutide and metformin in subjects with type 2 diabetes.A 26-week, randomised, open-label, parallel-group, multicentre, multinational trial with a 26-week extensioEUCTR2007-005317-19-FRovo Nordisk A/S940
进行中（未招募）
不适用
The effect of insulin detemir in combination with liraglutide and metformin compared to liraglutide and metformin in subjects with type 2 diabetes.A 26-week, randomised, open-label, parallel-group, multicentre, multinational trial with a 26-week extensioEUCTR2007-005317-19-BEovo Nordisk A/S940